India · Delayed Price · Currency is INR Dr. Reddy's Laboratories Statistics
Total Valuation
BOM:500124 has a market cap or net worth of INR 1.04 trillion. The enterprise value is 1.03 trillion.
| Market Cap | 1.04T |
| Enterprise Value | 1.03T |
Important Dates
The next confirmed earnings date is Wednesday, July 22, 2026.
| Earnings Date | Jul 22, 2026 |
| Ex-Dividend Date | Jul 10, 2026 |
Share Statistics
BOM:500124 has 832.69 million shares outstanding. The number of shares has decreased by -0.10% in one year.
| Current Share Class | 832.69M |
| Shares Outstanding | 832.69M |
| Shares Change (YoY) | -0.10% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 26.74% |
| Owned by Institutions (%) | 65.07% |
| Float | 599.68M |
Valuation Ratios
The trailing PE ratio is 24.22 and the forward PE ratio is 24.59. BOM:500124's PEG ratio is 3.41.
| PE Ratio | 24.22 |
| Forward PE | 24.59 |
| PS Ratio | 3.09 |
| PB Ratio | 2.73 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | 31.02 |
| P/OCF Ratio | 18.27 |
| PEG Ratio | 3.41 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.72, with an EV/FCF ratio of 30.81.
| EV / Earnings | 24.04 |
| EV / Sales | 3.07 |
| EV / EBITDA | 14.72 |
| EV / EBIT | 20.86 |
| EV / FCF | 30.81 |
Financial Position
The company has a current ratio of 1.80, with a Debt / Equity ratio of 0.20.
| Current Ratio | 1.80 |
| Quick Ratio | 1.13 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | 2.31 |
| Interest Coverage | 13.17 |
Financial Efficiency
Return on equity (ROE) is 11.84% and return on invested capital (ROIC) is 10.44%.
| Return on Equity (ROE) | 11.84% |
| Return on Assets (ROA) | 5.74% |
| Return on Invested Capital (ROIC) | 10.44% |
| Return on Capital Employed (ROCE) | 11.96% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | 12.20M |
| Profits Per Employee | 1.56M |
| Employee Count | 27,527 |
| Asset Turnover | 0.63 |
| Inventory Turnover | 2.15 |
Taxes
In the past 12 months, BOM:500124 has paid 12.35 billion in taxes.
| Income Tax | 12.35B |
| Effective Tax Rate | 22.53% |
Stock Price Statistics
The stock price has decreased by -1.89% in the last 52 weeks. The beta is 0.26, so BOM:500124's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | -1.89% |
| 50-Day Moving Average | 1,304.50 |
| 200-Day Moving Average | 1,267.65 |
| Relative Strength Index (RSI) | 35.78 |
| Average Volume (20 Days) | 120,618 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:500124 had revenue of INR 335.93 billion and earned 42.85 billion in profits. Earnings per share was 51.42.
| Revenue | 335.93B |
| Gross Profit | 177.26B |
| Operating Income | 49.25B |
| Pretax Income | 54.82B |
| Net Income | 42.85B |
| EBITDA | 68.15B |
| EBIT | 49.25B |
| Earnings Per Share (EPS) | 51.42 |
Balance Sheet
The company has 87.81 billion in cash and 77.34 billion in debt, with a net cash position of 10.47 billion or 12.58 per share.
| Cash & Cash Equivalents | 87.81B |
| Total Debt | 77.34B |
| Net Cash | 10.47B |
| Net Cash Per Share | 12.58 |
| Equity (Book Value) | 380.46B |
| Book Value Per Share | 452.82 |
| Working Capital | 134.41B |
Cash Flow
In the last 12 months, operating cash flow was 56.76 billion and capital expenditures -23.33 billion, giving a free cash flow of 33.43 billion.
| Operating Cash Flow | 56.76B |
| Capital Expenditures | -23.33B |
| Depreciation & Amortization | 18.90B |
| Net Borrowing | 18.99B |
| Free Cash Flow | 33.43B |
| FCF Per Share | 40.15 |
Margins
Gross margin is 52.77%, with operating and profit margins of 14.66% and 12.76%.
| Gross Margin | 52.77% |
| Operating Margin | 14.66% |
| Pretax Margin | 16.32% |
| Profit Margin | 12.76% |
| EBITDA Margin | 20.29% |
| EBIT Margin | 14.66% |
| FCF Margin | 9.95% |
Dividends & Yields
This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.64%.
| Dividend Per Share | 8.00 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 15.54% |
| Buyback Yield | 0.10% |
| Shareholder Yield | 0.74% |
| Earnings Yield | 4.13% |
| FCF Yield | 3.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:500124 is 1,338.18, which is 7.44% higher than the current price. The consensus rating is "Hold".
| Price Target | 1,338.18 |
| Price Target Difference | 7.44% |
| Analyst Consensus | Hold |
| Analyst Count | 39 |
| Revenue Growth Forecast (3Y) | 8.75% |
| EPS Growth Forecast (3Y) | 9.68% |
Stock Splits
The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.
| Last Split Date | Oct 28, 2024 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
BOM:500124 has an Altman Z-Score of 5.13 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.13 |
| Piotroski F-Score | 4 |